Information Library
Phase I/IIa - Central Lab
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Drug Information Association (DIA) US 2010
June 13 - June 16, 2010
Exhibit Dates: June 13 - 16, 2010 Exhibitor Booth Number: 1035 Quintiles Speakers: TBD -
Drug Information Association (DIA) Europe 2010
March 8 - March 10, 2010
22nd Annual EuroMeeting for the Drug Information Association -
QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS
September 24, 2009 - Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot building hosts more than 500 employees and has space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Validated Biomarker Menu
July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays. -
Clinical Development Services
June 18, 2009
Find out how large pharmaceutical companies and emerging biotech move products past each development milestone.
Page 1 of 1 (6 items)